Cargando…

Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite

Nanoparticles of gold with zinc oxide (Au@ZnO NPs) were prepared by laser ablation and then capped with curcumin nanoparticles (Cur-Au@ZnO NPs). The synthesized NPs were characterized using different techniques, including transmission electron microscopy (TEM), Fourier-transform infrared spectroscop...

Descripción completa

Detalles Bibliográficos
Autores principales: Jabir, Majid S., Rashid, Taha M., Nayef, Uday M., Albukhaty, Salim, AlMalki, Faizah A., Albaqami, Jawaher, AlYamani, Amal A., Taqi, Zainab J., Sulaiman, Ghassan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167132/
https://www.ncbi.nlm.nih.gov/pubmed/35669460
http://dx.doi.org/10.1155/2022/2663812
_version_ 1784720764370419712
author Jabir, Majid S.
Rashid, Taha M.
Nayef, Uday M.
Albukhaty, Salim
AlMalki, Faizah A.
Albaqami, Jawaher
AlYamani, Amal A.
Taqi, Zainab J.
Sulaiman, Ghassan M.
author_facet Jabir, Majid S.
Rashid, Taha M.
Nayef, Uday M.
Albukhaty, Salim
AlMalki, Faizah A.
Albaqami, Jawaher
AlYamani, Amal A.
Taqi, Zainab J.
Sulaiman, Ghassan M.
author_sort Jabir, Majid S.
collection PubMed
description Nanoparticles of gold with zinc oxide (Au@ZnO NPs) were prepared by laser ablation and then capped with curcumin nanoparticles (Cur-Au@ZnO NPs). The synthesized NPs were characterized using different techniques, including transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), UV-visible spectroscopy, and X-ray diffraction. In addition, the ability of NPs as a promising antibacterial agent was tested against Staphylococcus aureus through the agar well diffusion method and AO/EtBr staining assay. The results showed that the prepared nanoparticles (Cur-Au@ZnO) served as an antibacterial agent and can destroy the bacterial cells by losing the cell wall integrity and penetrating the cytoplasmic membrane. Moreover, the findings confirmed the role of the formed NPs in attenuation of the adherence and invasion of S. aureus to rat embryonic fibroblast (REF) cells. Furthermore, the activity of Cur-Au@ZnO NPs against the S. aureus α-hemolysin toxin was evaluated using the western blot technique, using human alveolar epithelial cells (A549), and through histopathology examination in a mouse model. In conclusion, the built Cur-Au@ZnO NPs can be used as a potential antibacterial agent and an inhibitor of α-hemolysin toxin secreted by S. aureus. These NPs may offer a new strategy in combating pathogen infections and in the future for biomedical and pharmaceutical applications.
format Online
Article
Text
id pubmed-9167132
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-91671322022-06-05 Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite Jabir, Majid S. Rashid, Taha M. Nayef, Uday M. Albukhaty, Salim AlMalki, Faizah A. Albaqami, Jawaher AlYamani, Amal A. Taqi, Zainab J. Sulaiman, Ghassan M. Bioinorg Chem Appl Research Article Nanoparticles of gold with zinc oxide (Au@ZnO NPs) were prepared by laser ablation and then capped with curcumin nanoparticles (Cur-Au@ZnO NPs). The synthesized NPs were characterized using different techniques, including transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), UV-visible spectroscopy, and X-ray diffraction. In addition, the ability of NPs as a promising antibacterial agent was tested against Staphylococcus aureus through the agar well diffusion method and AO/EtBr staining assay. The results showed that the prepared nanoparticles (Cur-Au@ZnO) served as an antibacterial agent and can destroy the bacterial cells by losing the cell wall integrity and penetrating the cytoplasmic membrane. Moreover, the findings confirmed the role of the formed NPs in attenuation of the adherence and invasion of S. aureus to rat embryonic fibroblast (REF) cells. Furthermore, the activity of Cur-Au@ZnO NPs against the S. aureus α-hemolysin toxin was evaluated using the western blot technique, using human alveolar epithelial cells (A549), and through histopathology examination in a mouse model. In conclusion, the built Cur-Au@ZnO NPs can be used as a potential antibacterial agent and an inhibitor of α-hemolysin toxin secreted by S. aureus. These NPs may offer a new strategy in combating pathogen infections and in the future for biomedical and pharmaceutical applications. Hindawi 2022-05-28 /pmc/articles/PMC9167132/ /pubmed/35669460 http://dx.doi.org/10.1155/2022/2663812 Text en Copyright © 2022 Majid S. Jabir et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jabir, Majid S.
Rashid, Taha M.
Nayef, Uday M.
Albukhaty, Salim
AlMalki, Faizah A.
Albaqami, Jawaher
AlYamani, Amal A.
Taqi, Zainab J.
Sulaiman, Ghassan M.
Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite
title Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite
title_full Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite
title_fullStr Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite
title_full_unstemmed Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite
title_short Inhibition of Staphylococcus aureus α-Hemolysin Production Using Nanocurcumin Capped Au@ZnO Nanocomposite
title_sort inhibition of staphylococcus aureus α-hemolysin production using nanocurcumin capped au@zno nanocomposite
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167132/
https://www.ncbi.nlm.nih.gov/pubmed/35669460
http://dx.doi.org/10.1155/2022/2663812
work_keys_str_mv AT jabirmajids inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite
AT rashidtaham inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite
AT nayefudaym inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite
AT albukhatysalim inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite
AT almalkifaizaha inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite
AT albaqamijawaher inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite
AT alyamaniamala inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite
AT taqizainabj inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite
AT sulaimanghassanm inhibitionofstaphylococcusaureusahemolysinproductionusingnanocurcumincappedauznonanocomposite